Results
RPG Life Sciences FY26 Net Profit ₹115.17 Crore
Board approved audited FY26 standalone and consolidated financial results with unmodified audit opinion.
Recommended a final dividend of ₹24 per share (300%) subject to shareholder approval at the AGM